{"id":"https://openalex.org/W3046779366","doi":"https://doi.org/10.1111/dth.14110","title":"Long\u2010term impact of adalimumab therapy on biomarkers of systemic inflammation in psoriasis: Results of a 2 year study","display_name":"Long\u2010term impact of adalimumab therapy on biomarkers of systemic inflammation in psoriasis: Results of a 2 year study","publication_year":2020,"publication_date":"2020-07-31","ids":{"openalex":"https://openalex.org/W3046779366","doi":"https://doi.org/10.1111/dth.14110","mag":"3046779366","pmid":"https://pubmed.ncbi.nlm.nih.gov/32734665"},"language":"en","primary_location":{"id":"doi:10.1111/dth.14110","doi":"https://doi.org/10.1111/dth.14110","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dth.14110","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dth.14110","source":{"id":"https://openalex.org/S67424211","display_name":"Dermatologic Therapy","issn_l":"1396-0296","issn":["1396-0296","1529-8019"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatologic Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dth.14110","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082499288","display_name":"Spyridon Gkalpakiotis","orcid":"https://orcid.org/0000-0002-6956-5961","observed_orcids":["https://orcid.org/0000-0002-6956-5961"]},"institutions":[{"id":"https://openalex.org/I21250087","display_name":"Charles University","ror":"https://ror.org/024d6js02","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]},{"id":"https://openalex.org/I4210156160","display_name":"University Hospital Kralovske Vinohrady","ror":"https://ror.org/04sg4ka71","country_code":"CZ","type":"healthcare","lineage":["https://openalex.org/I4210156160"]}],"countries":["CZ"],"is_corresponding":true,"raw_author_name":"Spyridon Gkalpakiotis","raw_affiliation_strings":["Third Faculty of Medicine, Department of Dermatology and Venereology, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic"],"raw_orcid":"https://orcid.org/0000-0002-6956-5961","affiliations":[{"raw_affiliation_string":"Third Faculty of Medicine, Department of Dermatology and Venereology, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic","institution_ids":["https://openalex.org/I21250087","https://openalex.org/I4210156160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087451143","display_name":"Monika Arenbergerov\u00e1","orcid":"https://orcid.org/0000-0002-7919-9619","observed_orcids":["https://orcid.org/0000-0002-7919-9619"]},"institutions":[{"id":"https://openalex.org/I21250087","display_name":"Charles University","ror":"https://ror.org/024d6js02","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]},{"id":"https://openalex.org/I4210156160","display_name":"University Hospital Kralovske Vinohrady","ror":"https://ror.org/04sg4ka71","country_code":"CZ","type":"healthcare","lineage":["https://openalex.org/I4210156160"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"Monika Arenbergerova","raw_affiliation_strings":["Third Faculty of Medicine, Department of Dermatology and Venereology, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic"],"raw_orcid":"https://orcid.org/0000-0002-7919-9619","affiliations":[{"raw_affiliation_string":"Third Faculty of Medicine, Department of Dermatology and Venereology, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic","institution_ids":["https://openalex.org/I21250087","https://openalex.org/I4210156160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076568628","display_name":"Petra Gkalpakioti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I21250087","display_name":"Charles University","ror":"https://ror.org/024d6js02","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]},{"id":"https://openalex.org/I4210156160","display_name":"University Hospital Kralovske Vinohrady","ror":"https://ror.org/04sg4ka71","country_code":"CZ","type":"healthcare","lineage":["https://openalex.org/I4210156160"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"Petra Gkalpakioti","raw_affiliation_strings":["Third Faculty of Medicine, Department of Dermatology and Venereology, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Third Faculty of Medicine, Department of Dermatology and Venereology, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic","institution_ids":["https://openalex.org/I21250087","https://openalex.org/I4210156160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005054306","display_name":"Jana Poto\u010dkov\u00e1","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I21250087","display_name":"Charles University","ror":"https://ror.org/024d6js02","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]},{"id":"https://openalex.org/I4210156160","display_name":"University Hospital Kralovske Vinohrady","ror":"https://ror.org/04sg4ka71","country_code":"CZ","type":"healthcare","lineage":["https://openalex.org/I4210156160"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"Jana Potockova","raw_affiliation_strings":["Third Faculty of Medicine, Second Department of Internal Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Third Faculty of Medicine, Second Department of Internal Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic","institution_ids":["https://openalex.org/I21250087","https://openalex.org/I4210156160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034356416","display_name":"Petr Arenberger","orcid":"https://orcid.org/0000-0002-4800-5877","observed_orcids":["https://orcid.org/0000-0002-4800-5877"]},"institutions":[{"id":"https://openalex.org/I21250087","display_name":"Charles University","ror":"https://ror.org/024d6js02","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]},{"id":"https://openalex.org/I4210156160","display_name":"University Hospital Kralovske Vinohrady","ror":"https://ror.org/04sg4ka71","country_code":"CZ","type":"healthcare","lineage":["https://openalex.org/I4210156160"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"Petr Arenberger","raw_affiliation_strings":["Third Faculty of Medicine, Department of Dermatology and Venereology, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Third Faculty of Medicine, Department of Dermatology and Venereology, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic","institution_ids":["https://openalex.org/I21250087","https://openalex.org/I4210156160"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032741239","display_name":"Pavel J. Kraml","orcid":"https://orcid.org/0000-0003-1354-0228","observed_orcids":["https://orcid.org/0000-0003-1354-0228"]},"institutions":[{"id":"https://openalex.org/I21250087","display_name":"Charles University","ror":"https://ror.org/024d6js02","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]},{"id":"https://openalex.org/I4210156160","display_name":"University Hospital Kralovske Vinohrady","ror":"https://ror.org/04sg4ka71","country_code":"CZ","type":"healthcare","lineage":["https://openalex.org/I4210156160"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"Pavel Kraml","raw_affiliation_strings":["Third Faculty of Medicine, Second Department of Internal Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Third Faculty of Medicine, Second Department of Internal Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic","institution_ids":["https://openalex.org/I21250087","https://openalex.org/I4210156160"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5082499288"],"corresponding_institution_ids":["https://openalex.org/I21250087","https://openalex.org/I4210156160"],"apc_list":{"value":3100,"currency":"USD","value_usd":3100},"apc_paid":null,"fwci":0.4279,"has_fulltext":true,"cited_by_count":8,"citation_normalized_percentile":{"value":0.55195301,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"33","issue":"6","first_page":"e14110","last_page":"e14110"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.824999988079071},{"id":"https://openalex.org/keywords/adalimumab","display_name":"adalimumab","score":1.0},{"id":"https://openalex.org/keywords/anti-tnf-therapy","display_name":"anti-TNF therapy","score":0.7870000004768372},{"id":"https://openalex.org/keywords/systemic-inflammation","display_name":"systemic inflammation","score":0.9890000224113464},{"id":"https://openalex.org/keywords/atherosclerosis-risk","display_name":"atherosclerosis risk","score":0.7429999709129333},{"id":"https://openalex.org/keywords/endothelial-dysfunction","display_name":"endothelial dysfunction","score":0.9679999947547913},{"id":"https://openalex.org/keywords/high-sensitivity-c-reactive-protein","display_name":"high-sensitivity C-reactive protein","score":0.9509999752044678},{"id":"https://openalex.org/keywords/oxidized-ldl","display_name":"oxidized LDL","score":0.9190000295639038},{"id":"https://openalex.org/keywords/e-selectin","display_name":"E-selectin","score":1.0},{"id":"https://openalex.org/keywords/il-22","display_name":"IL-22","score":0.9089999794960022},{"id":"https://openalex.org/keywords/inflammatory-markers","display_name":"inflammatory markers","score":0.7509999871253967}],"concepts":[{"id":"https://openalex.org/C2780132546","wikidata":"https://www.wikidata.org/wiki/Q348260","display_name":"Adalimumab","level":3,"score":0.9418208003044128},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9416937828063965},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.8819035291671753},{"id":"https://openalex.org/C2776252253","wikidata":"https://www.wikidata.org/wiki/Q7663815","display_name":"Systemic inflammation","level":3,"score":0.7954387664794922},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.6412264704704285},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6330437064170837},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.6027059555053711},{"id":"https://openalex.org/C2781195455","wikidata":"https://www.wikidata.org/wiki/Q422766","display_name":"C-reactive protein","level":3,"score":0.5234548449516296},{"id":"https://openalex.org/C65409693","wikidata":"https://www.wikidata.org/wiki/Q425265","display_name":"Statistical significance","level":2,"score":0.42555418610572815},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.3993995785713196},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3378356099128723}],"mesh":[{"descriptor_ui":"D000068879","descriptor_name":"Adalimumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/dth.14110","doi":"https://doi.org/10.1111/dth.14110","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dth.14110","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dth.14110","source":{"id":"https://openalex.org/S67424211","display_name":"Dermatologic Therapy","issn_l":"1396-0296","issn":["1396-0296","1529-8019"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatologic Therapy","raw_type":"journal-article"},{"id":"pmid:32734665","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32734665","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatologic therapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/dth.14110","doi":"https://doi.org/10.1111/dth.14110","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dth.14110","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dth.14110","source":{"id":"https://openalex.org/S67424211","display_name":"Dermatologic Therapy","issn_l":"1396-0296","issn":["1396-0296","1529-8019"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatologic Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2872801405","display_name":null,"funder_award_id":"PROGRESS Q28","funder_id":"https://openalex.org/F4320309755","funder_display_name":"Univerzita Karlova v Praze"},{"id":"https://openalex.org/G5148399815","display_name":null,"funder_award_id":"Progress Q36","funder_id":"https://openalex.org/F4320309755","funder_display_name":"Univerzita Karlova v Praze"}],"funders":[{"id":"https://openalex.org/F4320309755","display_name":"Univerzita Karlova v Praze","ror":"https://ror.org/024d6js02"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3046779366.pdf","grobid_xml":"https://content.openalex.org/works/W3046779366.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W1483095827","https://openalex.org/W1488789440","https://openalex.org/W1583142887","https://openalex.org/W1723679484","https://openalex.org/W1891095283","https://openalex.org/W2022656985","https://openalex.org/W2034956536","https://openalex.org/W2057448387","https://openalex.org/W2063997025","https://openalex.org/W2064168005","https://openalex.org/W2069997798","https://openalex.org/W2095652983","https://openalex.org/W2117521530","https://openalex.org/W2126412451","https://openalex.org/W2140998385","https://openalex.org/W2158489950","https://openalex.org/W2236972161","https://openalex.org/W2535103096","https://openalex.org/W2587863476","https://openalex.org/W2599705593","https://openalex.org/W2607491620","https://openalex.org/W2612927818","https://openalex.org/W2753536197","https://openalex.org/W2782738693","https://openalex.org/W2795583931","https://openalex.org/W2860095218","https://openalex.org/W2887196980","https://openalex.org/W2969510650","https://openalex.org/W3005369051","https://openalex.org/W3008728180","https://openalex.org/W6681068697"],"related_works":["https://openalex.org/W2535103096","https://openalex.org/W2612927818","https://openalex.org/W3117111281","https://openalex.org/W2804753859","https://openalex.org/W2731573929","https://openalex.org/W2909343693","https://openalex.org/W1978515253","https://openalex.org/W2802545951","https://openalex.org/W3085591136","https://openalex.org/W3047798852"],"abstract_inverted_index":{"Psoriasis":[0,106],"patients":[1,91,107,157],"are":[2],"at":[3,185],"increased":[4,109],"risk":[5],"of":[6,25,33,61,102,111,122,192],"atherosclerosis,":[7],"characterized":[8],"by":[9],"endothelial":[10],"dysfunction,":[11],"linked":[12],"through":[13],"systemic":[14,38,204],"inflammation.":[15,205],"Anti-TNF-a":[16],"therapy":[17],"seems":[18],"to":[19,29,44,48,115],"decrease":[20,191],"this":[21,26],"risk.":[22],"The":[23,189],"purpose":[24],"study":[27],"was":[28],"measure":[30],"the":[31,50,116],"levels":[32,54,110],"serum":[34],"markers":[35,82,112],"associated":[36],"with":[37,92,104,162],"inflammation":[39],"in":[40,52,85,89,113],"psoriasis":[41,94],"patients,":[42,166],"compared":[43],"healthy":[45,86],"individuals":[46],"and":[47,58,77,88,96,99,175,195],"investigate":[49],"change":[51],"their":[53],"after":[55,97,197],"3":[56,98,120],"months":[57,101,121,199],"2":[59],"years":[60],"adalimumab":[62,202],"therapy.":[63],"We":[64],"investigated":[65],"four":[66],"biomarkers:":[67],"high-sensitivity":[68],"C-reactive":[69],"protein":[70],"(hsCRP),":[71],"oxidized":[72],"low-density":[73],"lipoproteins":[74],"(OxLDL),":[75],"E-selectin,":[76,193],"Interleukin":[78],"22":[79],"(IL-22).":[80],"These":[81],"were":[83,148,158,180],"measured":[84],"volunteers":[87],"28":[90],"moderate/severe":[93],"before":[95],"24":[100,154,198],"treatment":[103],"adalimumab.":[105,163],"had":[108],"comparison":[114],"control":[117],"group.":[118],"After":[119,153],"therapy,":[123],"E-selectin":[124,171],"decreased":[125,139],"significantly":[126,181],"(P":[127,134,168,172,177],"<":[128,135,169,173,178],".001),":[129],"as":[130,132],"well":[131],"IL-22":[133,176,196],".001).":[136],"hsCRP":[137,167],"also":[138],"but":[140],"did":[141],"not":[142],"show":[143],"a":[144,186],"statistical":[145],"significance,":[146],"OxLDL":[147,183],"slightly":[149],"higher":[150,187],"than":[151],"initially.":[152],"months,":[155],"17":[156],"still":[159],"being":[160],"treated":[161],"In":[164],"these":[165],".05),":[170],".001)":[174,179],"decreased.":[182],"remained":[184],"level.":[188],"stable":[190],"hsCRP,":[194],"confirms":[200],"that":[201],"suppresses":[203]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2020-08-07T00:00:00"}